Filing Details

Accession Number:
0001753926-24-001578
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-09-16 16:56:55
Reporting Period:
2024-09-12
Accepted Time:
2024-09-16 16:56:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1919246 Chromocell Therapeutics Corp CHRO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1772168 Richard Malamut C/O Chromocell Therapeutics Corporation
4400 Route 9 South, Suite 1000
Freehold NJ 07728
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-09-12 10,400 $0.94 91,565 No 4 P Indirect Jointly held with spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Jointly held with spouse
Footnotes
  1. This price represents the weighted average price of the shares purchased ranging from $0.9206 to $0.9554 per share, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.